|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US7419829B2
(en)
|
2000-10-06 |
2008-09-02 |
Oxford Biomedica (Uk) Limited |
Vector system
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
EP1438075A4
(en)
|
2001-10-02 |
2006-04-19 |
Inst Clayton De La Rech |
METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS
|
|
US7816131B2
(en)
|
2004-04-02 |
2010-10-19 |
Board Of Regents, The University Of Texas System |
Cancer specific promoters
|
|
US9725485B2
(en)
*
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
US8865881B2
(en)
|
2011-02-22 |
2014-10-21 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (AAV) vectors
|
|
GB201206455D0
(en)
|
2012-04-12 |
2012-05-30 |
Royal Holloway & Bedford New College |
Gene expression
|
|
CA2876285A1
(en)
*
|
2012-08-08 |
2014-02-13 |
Roche Glycart Ag |
Interleukin-10 fusion proteins and uses thereof
|
|
JP2016517440A
(ja)
|
2013-03-15 |
2016-06-16 |
ブイエルピー バイオテック，インコーポレイテッド |
パリビズマブエピトープベースのウイルス様粒子
|
|
WO2014152232A2
(en)
|
2013-03-15 |
2014-09-25 |
Dyax Corp. |
Anti-plasma kallikrein antibodies
|
|
IL295414B2
(en)
*
|
2014-03-27 |
2026-02-01 |
Takeda Pharmaceuticals Co |
Compositions and methods for treating macular edema due to diabetes
|
|
US20160130324A1
(en)
*
|
2014-10-31 |
2016-05-12 |
Shire Human Genetic Therapies, Inc. |
C1 Inhibitor Fusion Proteins and Uses Thereof
|
|
CN107249646B
(zh)
|
2014-12-16 |
2021-06-29 |
内布拉斯加大学董事会 |
用于青少年巴滕病的基因疗法
|
|
CL2014003590A1
(es)
|
2014-12-30 |
2015-07-10 |
Univ Chile |
Virus aav/xbp1s-ha, método de tratamiento genético y su uso en la optimizacion y mejoramiento de las capacidades cognitivas, de memoria y de aprendizaje.
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
EP3270944B1
(en)
*
|
2015-03-17 |
2019-10-23 |
Vrije Universiteit Brussel |
Optimized liver-specific expression systems for fviii and fix
|
|
US10179918B2
(en)
|
2015-05-07 |
2019-01-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increasing transgene activity
|
|
GB2547179A
(en)
|
2015-10-26 |
2017-08-16 |
Quethera Ltd |
Genetic construct
|
|
CN108291238A
(zh)
|
2015-10-27 |
2018-07-17 |
赛尔希恩公司 |
嵌合转录后调控元件
|
|
CN109415687A
(zh)
|
2016-04-07 |
2019-03-01 |
蓝鸟生物公司 |
嵌合抗原受体t细胞组合物
|
|
JP7632835B2
(ja)
|
2016-05-20 |
2025-02-19 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
加齢関連疾患及び症状の遺伝子治療法
|
|
CN110662839A
(zh)
|
2017-02-17 |
2020-01-07 |
珀杜研究基金会 |
用于细胞疗法的基于靶向性配体-有效负载的药物递送
|
|
CN110945127B
(zh)
*
|
2017-05-22 |
2024-07-12 |
武田药品工业株式会社 |
用于血友病b的基因疗法的编码具有增加的表达的重组fix的病毒载体
|
|
BR112020007405A2
(pt)
*
|
2017-10-18 |
2020-12-08 |
Regenxbio Inc. |
Produtos terapêuticos de anticorpo pós-translacionalmente modificados totalmente humanos
|